¿Desechan correctamente los pacientes sus dispositivos de inhalación? Proyecto AIRE

  1. R. de Simón Gutiérrez 1
  2. L. Ginel Mendoza 2
  3. A. Hidalgo Requena 3
  4. D. Rico Munilla 4
  5. F. Cantalapiedra Fernández 5
  1. 1 Centro de Salud Luis Vives, SEMERGEN, Alcalá de Henares, España
  2. 2 Centro de Salud Ciudad Jardín, SEMERGEN, Málaga, España
  3. 3 Unidad de Gestión Clínica de Lucena, SEMERGEN, Córdoba, España
  4. 4 Farmacia Rico Munilla, SEFAC, Madrid, España
  5. 5 Farmacia Cantalapiedra, SEFAC, Alcalá de Henares, España
Mostrar afiliaciones +
Revista:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Año de publicación: 2022

Número: 1

Páginas: 14-22

Tipo: Artículo

DOI: 10.1016/J.SEMERG.2021.07.011 DIALNET GOOGLE SCHOLAR

Otras publicaciones en: Semergen: revista española de medicina de familia

Resumen

Objectives To assess users’ attitudes and knowledge of users about how and where inhalers are removed after finalizing their use, and to describe their opinion about utilizing re-usable inhalers. Methods Cross-sectional, multi-center, and opinion survey, conducted to assess behavior and attitudes regarding the disposal of inhalers recycling and the use of re-usable inhalers, through the application of an ad hoc questionnaire about the knowledge and attitudes, with data about the use and recycling of inhalers. Results A total of 303 subjects (57.5±19.9 years; time of inhalers’ use 9.6±9.8 years; asthma/COPD: 46.2%/25.7%) were included. Pressurized metered-dose inhalers were the most commonly used inhalers (30.5%). Most users considered the recycling of inhalers to be very important (7.75±2.76, out of 10), and rated highly the availability of having a monthly rechargeable inhaler every 6 months (7.77±2.79, out of 10). Only 33% of users had been informed by their healthcare professionals about the place of delivering the inhaler. With respect to recycling, 42.9% of all users recycled in the SIGRE point of the pharmacy. Regarding the final destination of inhalers, 43.6% thought that the removed inhalers were recycled or destroyed, but 35.3% did not know what would happen to the inhalers after placing in the SIGRE point. Conclusions Despite users considered the importance of inhalers recycling and the availability of re-usable inhalers, a significant proportion does not recycle in the SIGRE point, has not been informed about the appropriate place of delivering the inhaler and ignores what happens to inhalers. Information campaigns are warranted.

Referencias bibliográficas

  • J. Domínguez-Ortega, F.J. Sáez-Martínez, J.T. Gómez-Sáenz, J. Molina-París, F.J. Álvarez-Gutiérrez El manejo del asma como enfermedad inflamatoria crónica y problema sanitario global: documento de posicionamiento de las sociedades científicas Semergen., 46 (2020), pp. 347-354 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • J.T. Gómez Sáenz, J.A. Quintano Jiménez, A. Hidalgo Requena, M. González Béjar, M.J. Gérez Callejas, M.R. Zangróniz Uruñuela, et al. Enfermedad pulmonar obstructiva crónica: morbimortalidad e impacto sanitario Semergen., 40 (2014), pp. 198-204 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • J. Starup-Hansen, H. Dunne, J. Sadler, A. Jones, M. Okorie Climate change in healthcare: Exploring the potential role of inhaler prescribing Pharmacol Res Perspect., 8 (2020), p. e00675 View PDFView Record in ScopusGoogle Scholar
  • J.N. Pritchard The Climate is Changing for Metered-Dose Inhalers and Action is Needed Drug Des Devel Ther., 14 (2020), pp. 3043-3055 View PDFCrossRefView Record in ScopusGoogle Scholar
  • A. Pérez Torres, V.J. Baixauli Fernández Tratamiento residual de los medicamentos (I). Envases y residuos OFFARM., 20 (2001), pp. 114-122 View Record in ScopusGoogle Scholar
  • K. Liew, A. Wilkinson How do we choose inhalers? Patient and physician perspectives on environmental, financial and ease-of-use factor Thorax., 72 (2017), pp. A235-A237 P280 View PDFCrossRefView Record in ScopusGoogle Scholar
  • A. Ramón, S. Armengol, E. Ortiz, N. González-Rojas Horizonte 2030: ¿Es la sostenibilidad un factor importante en la elección del tratamiento de los pacientes con EPOC? XXXIX Jornadas de Economía de la Salud, Albacete (2019), p. 59 View Record in ScopusGoogle Scholar
  • P. López Pereira, A.M. Gandarillas Grande, L. Díez Gañán, M. Ordobás Gavín Evolución de la prevalencia de asma y factores sociodemográficos y de salud asociados en población de 18 a 64 años de la Comunidad de Madrid (1996-2013) Rev Esp Salud Pública., 91 (2017), pp. e1-e14 Google Scholar
  • M. Miravitllesa, J.J. Soler-Cataluña, M. Calle, J. Molina, P. Almagro, J.A. Quintano, et al. Guía española de la EPOC (GesEPOC). Actualización 2014 Arch Bronconeumol., 50 (Supl 1) (2014), pp. 1-16 View Record in ScopusGoogle Scholar
  • J. Giner Donaire, E. Tálamo Carrillo, V. Plaza Moral Área de asma de SEPAR, Área de enfermería de SEPAR, Departamento de asma ALAT. Consenso SEPAR-ALAT sobre terapia inhalada Arch Bronconeumol., 49 (S1) (2013), pp. 2-14 View Record in ScopusGoogle Scholar
  • A.J.K. Wilkinson, R. Braggins, I. Steinbach, J. Smith Costs of switching to low global warming potential inhalers An economic and carbon footprint analysis of NHS prescription data in England BMJ Open., 9 (2019), p. e028763 View PDFCrossRefView Record in ScopusGoogle Scholar
  • F. Lavorini, G.A. Fontana, O.S. Usmani New inhaler devices - the good, the bad and the ugly Respiration., 88 (2014), pp. 3-15 View PDFCrossRefView Record in ScopusGoogle Scholar
  • P.N. Dekhuijzen, F. Lavorini, O.S. Usmani Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat(®) or HandiHaler(®) Patient Prefer Adherence., 10 (2016), pp. 1561-1572 View PDFView Record in ScopusGoogle Scholar
  • H. Chrystyn, M. Small, G. Milligan, V. Higgins, E.G. Gil, J. Estruch Impact of patients’ satisfaction with their inhalers on treatment compliance and health status in COPD Respir Med., 108 (2014), pp. 358-365 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • M.J. Mäkelä, V. Backer, M. Hedegaard, K. Larsson Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD Respir Med., 107 (2013), pp. 1481-1490 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • R. Dhand, J. Eicher, M. Hänsel, I. Jost, M. Meisenheimer, H. Wachtel Improving usability and maintaining performance: human-factor and aerosol-performance studies evaluating the new reusable Respimat inhaler Int J Chron Obstruct Pulmon Dis., 14 (2019), pp. 509-523 View PDFCrossRefView Record in ScopusGoogle Scholar
  • M. Hänsel, T. Bambach, H. Wachtel Reduced Environmental Impact of the Reusable Respimat® Soft Mist(Inhaler Compared with Pressurised Metered-Dose Inhalers Adv Ther., 36 (2019), pp. 2487-2492 View PDFCrossRefView Record in ScopusGoogle Scholar
  • G. Ortsäter, F. Borgström, S. Soulard, C. Miltenburger A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT® Re-usable in the Nordics and Benelux Adv Ther., 36 (2019), pp. 3435-3445 View PDFCrossRefView Record in ScopusGoogle Scholar
  • B. Thomas, P. Sukumara, D. George, M. Midhun, M. Nainan Are we handling used metered dose inhaler canisters safely? – A call for action to address an environmental hazard IP Indian J Immunol Respir Med., 4 (2019), pp. 24-26 View PDFCrossRefView Record in ScopusGoogle Scholar
  • M. Hänsel, T. Bambach, H. Wachtel Reduced environmental impact of a reusable soft mist inhaler Eur Resp J., 52 (Suppl 62) (2018), p. 1021PA Google Scholar
  • C. Chouaid, N. Germain, G. De Pouvourville, S. Aballéa, D. Korchagina, M. Baldwin, et al. Patient preference for chronic obstructive pulmonary disease (COPD) treatment inhalers: a discrete choice experiment in France Curr Med Res Opin., 35 (2019), pp. 785-792 View PDFCrossRefView Record in ScopusGoogle Scholar
Fuente de los datos: Dialnet